Langkilde, Fredrik http://orcid.org/0000-0002-8706-4036
Masaba, Patrick
Edenbrandt, Lars
Gren, Magnus
Halil, Airin
Hellström, Mikael
Larsson, Måns
Naeem, Ameer Ali
Wallström, Jonas
Maier, Stephan E. http://orcid.org/0000-0003-0646-3893
Jäderling, Fredrik http://orcid.org/0000-0002-9042-7328
Funding for this research was provided by:
ALF agreement (ALFGBG-932648)
Vetenskapsrådet
Cancerfonden
University of Gothenburg
Article History
Received: 14 June 2023
Revised: 6 November 2023
Accepted: 10 November 2023
First Online: 2 January 2024
Declarations
:
: The scientific guarantor of this publication is Fredrik Jäderling.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: Marianne Månsson, PhD, Associate Professor, Statistician, Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, kindly provided statistical advice for this manuscript.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in:Hugosson J, Månsson M, Wallström J, Axcrona U, Carlsson SV, Egevad L, et al Prostate cancer screening with PSA and MRI followed by targeted biopsy only. New England Journal of Medicine. 2022;387(23):2126–37.
: • retrospective• observational• performed at one institution